Atrium Therapeutics annual operating margin
2023
2024
2025
Atrium Therapeutics Operating Margin Growth & History (RNA)
Atrium Therapeutics's operating margin was −412.58% for fiscal 2025.
View full Atrium Therapeutics company overviewAtrium Therapeutics annual operating margin history
| Fiscal year | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | −412.58% | −291.28 pp |
| 2024 | 2024-12-31 | −121.30% | −55.90 pp |
| 2023 | 2023-12-31 | −65.40% | — |
Atrium Therapeutics quarterly operating margin
Q4.24
Q1.26
Q2.26
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| Q2 2026 · Jun 30 | 2026-06-30 | −752.93% | −418.54 pp |
| Q1 2026 · Mar 31 | 2026-03-31 | −88.01% | +385.74 pp |
| Q4 2025 | 2025-12-31 | −5,591.97% | −4103.61 pp |
| Q3 2025 | 2025-09-30 | −68.59% | — |
| Q2 2026 · Jun 30 | 2025-06-30 | −334.39% | — |
| Q1 2026 · Mar 31 | 2025-03-31 | −473.74% | — |
| Q4 2024 | 2024-12-31 | −1,488.36% | — |
Atrium Therapeutics operating margin trends
Between the periods ended 2023-12-31 and 2025-12-31, Atrium Therapeutics's operating margin decreased from −65.40% to −412.58%, a change of −347.18 percentage points. The latest reported quarter, Q2 2026 · Jun 30, shows −752.93%.
About the metric
What operating margin means
Operating margin measures the percentage of revenue left after operating costs and expenses. It shows how much operating profit a company generates from each dollar of revenue.
Calculation and source
How operating margin is calculated
TickerStat calculates operating margin as SEC-reported operating income divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Atrium Therapeutics source filings ↗